National Bank of Canada’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,000
Closed -$3.64M 2867
2024
Q1
$3.64M Buy
+11,000
New +$2.7M 0.01% 886
2023
Q4
Sell
-132
Closed -$25.9K 2928
2023
Q3
$25.9K Hold
132
﹤0.01% 1976
2023
Q2
$37.7K Sell
132
-54
-29% -$15K ﹤0.01% 1850
2023
Q1
$40.3K Sell
186
-2
-1% -$390 ﹤0.01% 1772
2022
Q4
$38.6K Sell
188
-252
-57% -$63.7K ﹤0.01% 1814
2022
Q3
$122K Buy
440
+220
+100% +$55.9K ﹤0.01% 1479
2022
Q2
$42K Hold
220
﹤0.01% 1813
2022
Q1
$46K Sell
220
-9,399
-98% -$1.55M ﹤0.01% 1900
2021
Q4
$1.71M Buy
+9,619
New +$1.9M 0.01% 871

Other funds holding SWAV

National Bank of Canada's SWAV Position: Q2 2024 in Review

National Bank of Canada sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 11,000 shares — an estimated $3.64M sold.

National Bank of Canada first reported a position in SWAV in Q4 2021 and held it in 9 quarters. The position peaked at $3.64M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • National Bank of Canada reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • National Bank of Canada sold 11,000 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.64M.
  • National Bank of Canada first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • National Bank of Canada's Shockwave Medical, Inc. Common Stock position peaked at $3.64M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on National Bank of Canada's 13F filing for Q2 2024, filed 2 Aug 2024.